Have your own idea? Try our Stock Screener
U.K. (FTSE) Life Sciences Industry Analysis
UpdatedJun 16, 2026
DataAggregated Company Financials
Companies7
- 7D-8.5%
- 3M-4.5%
- 1Y-0.9%
- YTD-5.6%
Over the last 7 days, the Life Sciences industry has dropped 8.5%, driven by a pullback from Oxford Nanopore Technologies of 9.7%. As for the longer term, the industry's performance has been flat for the past year. Looking forward, earnings are forecast to grow by 57% annually.
Industry Valuation and Performance
Has the U.K. Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 16 Jun 2026 | UK£1.4b | UK£323.0m | -UK£166,018,254.00 | 1243.9x | -8.3x | 4.2x |
| Thu, 14 May 2026 | UK£1.4b | UK£318.2m | -UK£167,469,254.00 | n/a | -8.4x | 4.4x |
| Sat, 11 Apr 2026 | UK£1.3b | UK£323.0m | -UK£156,192,254.00 | 9.7x | -8.1x | 3.9x |
| Mon, 09 Mar 2026 | UK£1.4b | UK£324.0m | -UK£161,423,254.00 | 10.7x | -8.7x | 4.3x |
| Wed, 04 Feb 2026 | UK£1.7b | UK£304.6m | -UK£159,441,254.00 | 7.9x | -10.8x | 5.6x |
| Fri, 02 Jan 2026 | UK£1.4b | UK£304.6m | -UK£159,441,254.00 | 8.1x | -9x | 4.7x |
| Sun, 30 Nov 2025 | UK£1.6b | UK£303.9m | -UK£162,910,254.00 | 7.3x | -9.7x | 5.2x |
| Tue, 28 Oct 2025 | UK£1.6b | UK£304.3m | -UK£163,156,254.00 | 8.9x | -9.5x | 5.1x |
| Thu, 25 Sep 2025 | UK£1.7b | UK£304.0m | -UK£163,375,352.00 | 10.4x | -10.5x | 5.7x |
| Sat, 23 Aug 2025 | UK£2.2b | UK£291.9m | -UK£160,968,352.00 | 6.4x | -13.9x | 7.6x |
| Mon, 21 Jul 2025 | UK£1.6b | UK£291.9m | -UK£160,968,352.00 | 6.5x | -10.1x | 5.6x |
| Wed, 18 Jun 2025 | UK£1.5b | UK£319.7m | -UK£191,065,872.40 | 6.7x | -8x | 4.8x |
| Fri, 16 May 2025 | UK£1.7b | UK£313.2m | -UK£192,946,626.50 | 11.6x | -8.6x | 5.3x |
| Sun, 13 Apr 2025 | UK£1.5b | UK£315.4m | -UK£186,148,089.85 | 6.3x | -8.3x | 4.9x |
| Tue, 11 Mar 2025 | UK£1.5b | UK£321.2m | -UK£182,207,857.52 | 6.6x | -8x | 4.5x |
| Thu, 06 Feb 2025 | UK£2.0b | UK£306.8m | -UK£195,404,563.20 | 7.2x | -10x | 6.4x |
| Sat, 04 Jan 2025 | UK£1.9b | UK£307.0m | -UK£195,622,552.80 | 7.4x | -9.7x | 6.2x |
| Mon, 02 Dec 2024 | UK£2.1b | UK£306.3m | -UK£194,748,532.32 | 8.5x | -10.7x | 6.8x |
| Wed, 30 Oct 2024 | UK£1.9b | UK£304.6m | -UK£192,470,998.90 | 10.1x | -10x | 6.3x |
| Fri, 27 Sep 2024 | UK£2.1b | UK£303.6m | -UK£191,484,550.50 | 11.3x | -11.1x | 7x |
| Sun, 25 Aug 2024 | UK£1.8b | UK£295.5m | -UK£188,218,412.70 | 12.4x | -9.8x | 6.3x |
| Tue, 23 Jul 2024 | UK£1.8b | UK£295.2m | -UK£189,680,271.81 | 12.9x | -9.4x | 6x |
| Thu, 20 Jun 2024 | UK£1.5b | UK£297.1m | -UK£190,150,523.43 | 11.5x | -8.1x | 5.2x |
| Sat, 18 May 2024 | UK£1.6b | UK£294.6m | -UK£187,453,754.66 | 8063.9x | -8.7x | 5.6x |
| Mon, 15 Apr 2024 | UK£1.6b | UK£317.8m | -UK£178,579,491.35 | 12.2x | -9x | 5.1x |
| Wed, 13 Mar 2024 | UK£1.9b | UK£292.9m | -UK£212,454,146.91 | 7175.4x | -8.9x | 6.5x |
| Fri, 09 Feb 2024 | UK£2.1b | UK£285.9m | -UK£189,329,652.95 | 7108.2x | -11x | 7.3x |
| Sun, 07 Jan 2024 | UK£3.1b | UK£450.0m | -UK£173,987,191.00 | 62.1x | -17.9x | 6.9x |
| Tue, 05 Dec 2023 | UK£3.1b | UK£455.3m | -UK£169,049,937.00 | 50.5x | -18.1x | 6.7x |
| Thu, 02 Nov 2023 | UK£2.9b | UK£458.8m | -UK£165,724,639.00 | 46.8x | -17.8x | 6.4x |
| Sat, 30 Sep 2023 | UK£3.0b | UK£450.1m | -UK£168,316,472.00 | 66.1x | -17.9x | 6.7x |
| Mon, 28 Aug 2023 | UK£3.1b | UK£476.5m | -UK£126,784,080.00 | 70.6x | -24.2x | 6.4x |
| Wed, 26 Jul 2023 | UK£3.5b | UK£476.2m | -UK£124,457,941.00 | 69.6x | -27.8x | 7.3x |
| Fri, 23 Jun 2023 | UK£3.0b | UK£476.5m | -UK£124,693,426.00 | 66.1x | -23.9x | 6.3x |
Price to Earnings Ratio
-23.9x
Current Industry PE
- Investors are pessimistic on the British Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.8x is higher than the industry's current PS ratio of 4.2x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have deteriorated over the last three years.
- Revenues have also declined 12% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the U.K. Healthcare industry?
| GB Market | 0.74% | |
| Healthcare | -2.12% | |
| Life Sciences | -8.51% | |
| Clinical Research and Equipment | -8.51% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| IXI IXICO | UK£0.087 | 1.2% +UK£218.0k | -25.5% | PS2.6x |